Education and events 

Poster  -  21 February 2024

Rheumatologic Disorder Diagnostic Testing Patterns: Real World Evidence from a National Laboratory Database

Read Moreabout Rheumatologic Disorder Diagnostic Testing Patterns: Real World Evidence from a National Laboratory Database

Poster  -  21 February 2024

Biologic Drug and Anti-Drug Antibody Monitoring: All 5 TNF-Inhibitors, Infliximab, Adalimumab, Golimumab, Etanercept and Certolizumab Pegol, in 63,930 Patient Samples

Read Moreabout Biologic Drug and Anti-Drug Antibody Monitoring: All 5 TNF-Inhibitors, Infliximab, Adalimumab, Golimumab, Etanercept and Certolizumab Pegol, in 63,930 Patient Samples

Poster  -  21 February 2024

Novel Markers for Rheumatoid Arthritis, Anti-CarP, Anti-Sa, and Anti-CEP1, Are More Frequently Positive and Higher in Titer in RA Patients with Higher Vectra® Disease Activity Scores

Read Moreabout Novel Markers for Rheumatoid Arthritis, Anti-CarP, Anti-Sa, and Anti-CEP1, Are More Frequently Positive and Higher in Titer in RA Patients with Higher Vectra® Disease Activity Scores

Poster  -  20 February 2024

Correlation of Anti-Centromere Antibodies (ACA) Detection by Indirect Immunofluorescence (IFA) on HEp-2 Cells and by ELISA Demonstrates High Concordance but Highlights Advantage of IFA in Detecting ACA to All Centromere Protein (CENP) Antigens

Read Moreabout Correlation of Anti-Centromere Antibodies (ACA) Detection by Indirect Immunofluorescence (IFA) on HEp-2 Cells and by ELISA Demonstrates High Concordance but Highlights Advantage of IFA in Detecting ACA to All Centromere Protein (CENP) Antigens